Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
Harvard Business School
Express Scripts
Merck

Last Updated: May 20, 2022

Details for New Drug Application (NDA): 020812


✉ Email this page to a colleague

« Back to Dashboard

NDA 020812 describes PEDIATRIC ADVIL, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. Additional details are available on the PEDIATRIC ADVIL profile page.

The generic ingredient in PEDIATRIC ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020812
Tradename:PEDIATRIC ADVIL
Applicant:Glaxosmithkline
Ingredient:ibuprofen
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020812
Mechanism of Action Cyclooxygenase Inhibitors
Medical Subject Heading (MeSH) Categories for 020812
Analgesics, Non-Narcotic
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors
Suppliers and Packaging for NDA: 020812
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INFANT'S ADVIL ibuprofen SUSPENSION/DROPS;ORAL 020812 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0573-0191 0573-0191-20 1 BOTTLE, DROPPER in 1 CARTON (0573-0191-20) > 15 mL in 1 BOTTLE, DROPPER
INFANT'S ADVIL ibuprofen SUSPENSION/DROPS;ORAL 020812 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0573-0191 0573-0191-22 1 BOTTLE, DROPPER in 1 CARTON (0573-0191-22) > 15 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION/DROPS;ORALStrength100MG/2.5ML
Approval Date:Jan 30, 1998TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SUSPENSION/DROPS;ORALStrength50MG/1.25ML
Approval Date:Jan 12, 2000TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
AstraZeneca
Moodys
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group